← Back to Clinical Trials
Recruiting NCT07147062

NCT07147062 Comparison of the Postoperative Analgesic Effects of RSB and CEB in Pediatric Patients Scheduled for Percutaneous Internal Ring Suturing

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07147062
Status Recruiting
Phase
Sponsor Diskapi Yildirim Beyazit Education and Research Hospital
Condition Percutaneous Internal Ring Suturing
Study Type INTERVENTIONAL
Enrollment 65 participants
Start Date 2025-09-08
Primary Completion 2026-02-13

Eligibility & Interventions

Sex All sexes
Min Age 1 Year
Max Age 8 Years
Study Type INTERVENTIONAL
Interventions
Rectus Sheath BlockCaudal Epidural Block

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 65 participants in total. It began in 2025-09-08 with a primary completion date of 2026-02-13.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Inguinal hernia is one of the most common surgical pathologies in children, and the minimally invasive percutaneous internal ring suturing (PIRS) technique is widely preferred. By providing effective pain control, nerve blocks reduce postoperative opioid requirements, thereby minimising opioid-related adverse effects and lowering the risk of pulmonary and cardiovascular complications. This study aims to compare the postoperative analgesic effects of rectus sheath block and caudal epidural block in pediatric patients undergoing PIRS.

Eligibility Criteria

Inclusion Criteria: * Patients aged between 1 and 8 years * ASA physical status I-II * Patients who underwent PIRS surgery in the operating room and received either a rectus sheath block or a caudal epidural block Exclusion Criteria: * Patients younger than 1 year or older than 8 years * ASA physical status ≥ III * History of bleeding diathesis

Contact & Investigator

Central Contact

Elif Şule Özdemir Sezgi

✉ elifsule-91@hotmail.com

📞 00905059209638

Frequently Asked Questions

Who can join the NCT07147062 clinical trial?

This trial is open to participants of all sexes, aged 1 Year or older, up to 8 Years, studying Percutaneous Internal Ring Suturing. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07147062 currently recruiting?

Yes, NCT07147062 is actively recruiting participants. Contact the research team at elifsule-91@hotmail.com for enrollment information.

Where is the NCT07147062 trial being conducted?

This trial is being conducted at Altındağ, Turkey (Türkiye).

Who is sponsoring the NCT07147062 clinical trial?

NCT07147062 is sponsored by Diskapi Yildirim Beyazit Education and Research Hospital. The trial plans to enroll 65 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology